- Home
- KROS vs GRAL Comparison
KROS vs GRAL Comparison
Compare KROS & GRAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- GRAL
- Stock Information
- Founded
- KROS 2015
- GRAL 2016
- Country
- KROS United States
- GRAL United States
- Employees
- KROS 160
- GRAL N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- GRAL
- Sector
- KROS Health Care
- GRAL
- Exchange
- KROS Nasdaq
- GRAL NYSE
- Market Cap
- KROS 589.8M
- GRAL 610.9M
- IPO Year
- KROS 2020
- GRAL N/A
- Fundamental
- Price
- KROS $12.62
- GRAL $18.07
- Analyst Decision
- KROS Buy
- GRAL Hold
- Analyst Count
- KROS 11
- GRAL 2
- Target Price
- KROS $68.83
- GRAL $16.00
- AVG Volume (30 Days)
- KROS 2.0M
- GRAL 970.8K
- Earning Date
- KROS 02-26-2025
- GRAL 02-15-2025
- Dividend Yield
- KROS N/A
- GRAL N/A
- EPS Growth
- KROS N/A
- GRAL N/A
- EPS
- KROS N/A
- GRAL N/A
- Revenue
- KROS $651,000.00
- GRAL $117,669,000.00
- Revenue This Year
- KROS $224.66
- GRAL $32.48
- Revenue Next Year
- KROS N/A
- GRAL $14.72
- P/E Ratio
- KROS N/A
- GRAL N/A
- Revenue Growth
- KROS 8037.50
- GRAL 111.83
- 52 Week Low
- KROS $13.96
- GRAL $12.33
- 52 Week High
- KROS $73.00
- GRAL $24.92
- Technical
- Relative Strength Index (RSI)
- KROS 20.98
- GRAL N/A
- Support Level
- KROS $15.59
- GRAL N/A
- Resistance Level
- KROS $16.49
- GRAL N/A
- Average True Range (ATR)
- KROS 0.81
- GRAL 0.00
- MACD
- KROS 1.00
- GRAL 0.00
- Stochastic Oscillator
- KROS 3.41
- GRAL 0.00
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About GRAL GRAIL INC
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages.